Clinical Trial Update: Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine [NA]

View source ↗

Summary

This clinical trial compared continued zidovudine to switching to didanosine (ddI) in patients with AIDS or AIDS-related complex who were worsening on zidovudin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Aids-related Complex
• HIV Infection

Drugs mentioned

• Didanosine (didanosine)
• Zidovudine (Zidovudine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | NA | Status: COMPLETED